Molecular Characterization of Acquired Resistance To Anti-EGFR Monoclonal Antibodies in Colorectal Cancer Patients

被引：0
|
作者：
Bellosillo, Beatriz [1 ]
Dahnases, Alba [1 ]
Martinez, Alejandro [1 ]
Iglesias, Mar [1 ]
Gonzalez, Irio [1 ]
Salido, Marta [1 ]
Busto, Marcos [1 ]
Sanchez, Juan [1 ]
Vidal, Joana [1 ]
Clave, Sergi [1 ]
Moragon, Ester [1 ]
Pairet, Silvia [1 ]
Bellmunt, Joaquim [1 ]
Serrano, Sergio [1 ]
Rovira, Ana [1 ]
Albanell, Joan [1 ]
Montagut, Clara [1 ]
机构：
[1] Hosp del Mar, Barcelona, Spain
来源：
LABORATORY INVESTIGATION | 2015年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
583
引用
收藏
页码：148A / 148A
页数：1
相关论文
共 50 条
  • [31] Optimizing treatment of metastatic colorectal cancer patients with anti-EGFR antibodies: overcoming the mechanisms of cancer cell resistance
    Troiani, Teresa
    Zappavigna, Silvia
    Martinelli, Erika
    Addeo, Santolo R.
    Stiuso, Paola
    Ciardiello, Fortunato
    Caraglia, Michele
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (02) : 241 - 255
  • [32] Mechanisms of resistance to anti-EGFR therapy in colorectal cancer
    Zhao, Ben
    Wang, Lu
    Qiu, Hong
    Zhang, Mingsheng
    Sun, Li
    Peng, Ping
    Yu, Qianqian
    Yuan, Xianglin
    ONCOTARGET, 2017, 8 (03) : 3980 - 4000
  • [33] BRAF mutation predicts resistance to anti-EGFR monoclonal antibodies in wild-type KRAS metastatic colorectal cancer
    Chen Mao
    Ru-Yan Liao
    Qing Chen
    Journal of Cancer Research and Clinical Oncology, 2010, 136 : 1293 - 1294
  • [34] BRAF mutation predicts resistance to anti-EGFR monoclonal antibodies in wild-type KRAS metastatic colorectal cancer
    Mao, Chen
    Liao, Ru-Yan
    Chen, Qing
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (08) : 1293 - 1294
  • [35] Markers of resistance to anti-EGFR therapy in colorectal cancer
    Shaib, Walid
    Mahajan, Reena
    El-Rayes, Bassel
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2013, 4 (03) : 308 - 318
  • [36] Molecular Predictors of Efficacy to Anti-EGFR Agents in Colorectal Cancer Patients
    Ruzzo, A.
    Graziano, F.
    Canestrari, E.
    Magnani, M.
    CURRENT CANCER DRUG TARGETS, 2010, 10 (01) : 68 - 79
  • [37] IMMUNOLOGICAL EFFECTS OF DIFFERENT ANTI-EGFR ANTIBODIES IN METASTATIC COLORECTAL CANCER PATIENTS
    Manzoni, M.
    Delfanti, S.
    Rovati, B.
    Brugnatelli, S.
    Ronzoni, M.
    Perfetti, V
    Mariucci, S.
    Loupakis, F.
    Danova, M.
    ANNALS OF ONCOLOGY, 2010, 21 : 33 - 33
  • [38] Retreatment with anti-EGFR monoclonal antibodies in metastatic colorectal cancer: Systematic review of different strategies
    Mauri, Gianluca
    Pizzutilo, Elio Gregory
    Amatu, Alessio
    Bencardino, Katia
    Palmeri, Laura
    Bonazzina, Erica Francesca
    Tosi, Federica
    Stella, Giulia Carlo
    Burrafato, Giovanni
    Scaglione, Francesco
    Marsoni, Silvia
    Siravegna, Giulia
    Bardelli, Alberto
    Siena, Salvatore
    Sartore-Bianchi, Andrea
    CANCER TREATMENT REVIEWS, 2019, 73 : 41 - 53
  • [39] Resistance to anti-EGFR monoclonal antibodies in the treatment of head and neck carcinoma
    Lazo Roblejo, Yaily
    Morales Gonzalez, Maraelys
    ARS PHARMACEUTICA, 2021, 62 (04) : 389 - 403
  • [40] Molecular dissection of effector mechanisms of RAS-induced resistance to monoclonal anti-EGFR antibodies
    Kasper, S.
    Breitenbuecher, F.
    Markowetz, J.
    Reis, H.
    Ting, S.
    Worm, K.
    Meiler, J.
    Schmid, K. W.
    Trarbach, T.
    Schuler, M.
    ONKOLOGIE, 2013, 36 : 116 - 117
12345